Hemostemix Inc.

Hemostemix Inc.
Stock Exchange Toronto Ventures Stock Exchange
EPS
CAD0.03
Market Cap
CAD12.2 M
Shares Outstanding
300.9 M
Public Float
205.43 M

Profile

Address
300-5th Avenue SW
Calgary Alberta T2P 3C4
Canada
Employees -
Website http://www.hemostemix.com
Updated 07/08/2019
Hemostemix, Inc. is a clinical stage biotechnology company, which engages in the development, manufacture, and commercialization of blood-derived cell therapies to treat ischemic diseases. It focuses its operation in North America. The company was founded on March 26, 2012 and is headquartered in Calgary, Canada.

Financials

View All

Angus H. Jenkins
Chairman
David Leonard Wood
Director